Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

AI Stock Picker
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Resources

Blog
Earnings
Tutorial
Partner Program

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. XRAY
    4. >
  4. Valuation

Valuation

-
stocks logo
XRAY
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is XRAY Overvalued？

XRAY is now in the zone, suggesting that XRAY current forward PE ratio of 10.38 is considered compare with the five-year average of 18.77.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

XRAY Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
XRAY.O
DENTSPLY SIRONA Inc
10.38
Average P/E: 16.63
-95.69%
3.73B
stocks logo
PRCT.O
Procept Biorobotics Corp
loss
Average P/E: 16.63
20.88%
3.37B
stocks logo
NVST.N
Envista Holdings Corp
21.56
Average P/E: 16.63
100.55%
3.59B
stocks logo
IRTC.O
iRhythm Technologies Inc
loss
Average P/E: 16.63
96.63%
3.75B
stocks logo
SHC.O
Sotera Health Co
17.97
Average P/E: 16.63
222.43%
3.83B
stocks logo
ICUI.O
ICU Medical Inc
loss
Average P/E: 16.63
-554.39%
3.85B

XRAY Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

XRAY FAQs

Is XRAY currently overvalued based on its P/E ratio?

According to the provided data, XRAY's 5-year historical average forward P/E ratio is 18.77. XRAY forward P/E ratio is 10.38, which is categorized as Undervalued.

What is the significance of the EV/EBITDA ratio for XRAY?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has XRAY's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.34 to 1.43, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for XRAY's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

XRAY PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
18.77
Current PE
10.38
Overvalued PE
23.81
Undervalued PE
13.73

XRAY EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
13.37
Current EV
9.13
Overvalued EV
16.03
Undervalued EV
10.71

XRAY P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
2.23
Current PS
1.02
Overvalued PS
2.92
Undervalued PS
1.55

XRAY Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
XRAY.O
DENTSPLY SIRONA Inc
10.38
Average P/E: 16.63
-95.69%
3.73B
stocks logo
PRCT.O
Procept Biorobotics Corp
loss
Average P/E: 16.63
20.88%
3.37B
stocks logo
NVST.N
Envista Holdings Corp
21.56
Average P/E: 16.63
100.55%
3.59B
stocks logo
IRTC.O
iRhythm Technologies Inc
loss
Average P/E: 16.63
96.63%
3.75B
stocks logo
SHC.O
Sotera Health Co
17.97
Average P/E: 16.63
222.43%
3.83B
stocks logo
ICUI.O
ICU Medical Inc
loss
Average P/E: 16.63
-554.39%
3.85B

XRAY Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is XRAY undervalued？Is XRAY overvalued compared to its competitors？

XRAY FAQs

Is XRAY currently overvalued based on its P/E ratio?

According to the provided data, XRAY's 5-year historical average forward P/E ratio is 18.77. XRAY forward P/E ratio is 10.38, which is categorized as Undervalued.

What is the significance of the EV/EBITDA ratio for XRAY?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has XRAY's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.34 to 1.43, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for XRAY's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is XRAY undervalued？Is XRAY overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
AI Stock PickerFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisStock Chart PatternsEarnings TradingAI Screener
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free